Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: the case of hydroxychloroquine in COVID-19
L. Sala, V. Leonov, M. Mura, A. Moretti, L. Crotti, M. Gnecchi, P. J. Schwartz
This study uses hiPSC-derived cardiomyocytes to assess the proarrhythmic effects of hydroxychloroquine in healthy and LQTS patients, showing differential susceptibility to drug-induced arrhythmias.
bioRxiv · Jun 25, 2021Physiology